1. Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes. Issue 24 (13th December 2022) Authors: Scholtes, Rosalie A.; Hesp, Anne C.; Mosterd, Charlotte M.; Geurts, Frank; Hoorn, Ewout J.; Touw, Daan J.; Krebber, Merle M.; Joles, Jaap A.; Heerspink, Hiddo J.L.; van Raalte, Daniël H. Journal: Circulation Issue: Volume 146:Issue 24(2022) Page Start: 1895 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mechanisms underlying the blood pressure‐lowering effects of empagliflozin, losartan and their combination in people with type 2 diabetes: A secondary analysis of a randomized crossover trial. Issue 1 (27th September 2022) Authors: Scholtes, Rosalie A.; Mosterd, Charlotte M.; Hesp, Anne C.; Smits, Mark M.; Heerspink, Hiddo J. L.; van Raalte, Daniël H. Journal: Diabetes, obesity & metabolism Issue: Volume 25:Issue 1(2023) Page Start: 198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study. (6th May 2021) Authors: Bouman, Emma J.; Smits, Mark M.; van Bommel, Erik J.; Muskiet, Marcel H. A.; Hesp, Anne C.; Serné, Erik H.; Joles, Jaap A.; van Raalte, Daniël H. Journal: Microcirculation Issue: Volume 28:Number 6(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗